| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director | Common Stock | 20,000 | $157,800 | $7.89 | 12 Sep 2025 | Direct |
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 30,000 | 29 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | 12 Sep 2025 | 1 | +$157,800 | 4 | Director | 15 Sep 2025, 16:07 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 29 May 2025 | 1 | $0 | 4 | Director | 30 May 2025, 21:41 |
| OACC | Oaktree Acquisition Corp. III Life Sciences | 23 Oct 2024 | 0 | $0 | 3 | Director | 23 Oct 2024, 20:20 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 13 May 2024 | 1 | $0 | 4 | Director | 15 May 2024, 21:13 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 20 Jan 2024 | 1 | $0 | 4 | Director | 02 Feb 2024, 20:08 |
| ZVRA | ZEVRA THERAPEUTICS, INC. | 20 Jan 2024 | 0 | $0 | 3 | Director | 02 Feb 2024, 07:13 |